Correlation analysis of gut microbiota and metabolites in gastric cancer patients in plateau areas based on multi-omics technologies
Key Points
Gastric cancer patients exhibit distinct gut microbiota and metabolite profiles, indicating potential therapeutic targets.
Bacterial diversity analysis shows significant differences in patients compared to healthy controls, with specific metabolites linked to cancer progression.
Multi-omics technologies were employed to assess correlations between microbial communities and plasma metabolite levels in gastric cancer cases.
These findings underscore potential avenues for biomarker development in gastric cancer, warranting further exploration for clinical applicability.